A retrospective cross-sectional study comparing of sinonasal histopathological changes in biological treatment of eosinophilic chronic rhinosinusitis
Latest Information Update: 04 Jan 2022
At a glance
- Drugs Benralizumab (Primary) ; Mepolizumab (Primary)
- Indications Nasal polyps; Rhinosinusitis
- Focus Therapeutic Use
Most Recent Events
- 04 Jan 2022 New trial record
- 01 Jan 2022 Results published in the American Journal of Rhinology and Allergy